Urachal Cancer

• CLINICAL_TRIALS research · 2026-04-15
  Clinical Trial Update: Agnostic Therapy in Rare Solid Tumors [Phase 2]

  A Phase 2 trial of an agnostic therapy for multiple rare solid tumors is currently recruiting. The study lists a broad set of tumor types ac…

• CLINICAL_TRIALS research · 2025-12-30
  Clinical Trial Update: Trastuzumab Rezetecan in Advanced Solid Tumors Refractory to Standard Therapies [Phase 2]

  A Phase 2 clinical trial evaluating Trastuzumab Rezetecan in patients with urachal cancer and other advanced solid tumors is currently recru…

• CLINICAL_TRIALS research · 2025-09-09
  Clinical Trial Update: Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant [Phase 2]

  Phase 2 clinical trial evaluating a four-drug combination—fluorouracil, leucovorin, gemcitabine, and cisplatin—for metastatic or unresectabl…

• CLINICAL_TRIALS research · 2024-12-20
  Clinical Trial Update: Multi-cohort, Single-arm Phase II Study of Albumin-paclitaxel, Ifosfamide, and Cisplatin in the Treatment of Rare Advanced Tumors [Phase 2]

  Phase II, multi-cohort, single-arm trial evaluating a triplet regimen of albumin-bound paclitaxel, ifosfamide, and cisplatin in rare advance…

• CLINICAL_TRIALS trial_result · 2020-11-02
  Clinical Trial Update: A Multicenter Prospective Phase II Study of Modified FOLFIRINOX for 1st Line Treatment for Advanced Urachus Cancer [Phase 2]

  Phase II multicenter trial evaluating modified FOLFIRINOX as first-line therapy for advanced urachal cancer.

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.